Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : India Coffee House -- Ignore unavailable to you. Want to Upgrade?

To: Mohan Marette who wrote (6670)	9/10/1999 11:59:00 AM
From: Mohan Marette	Read Replies (1) \| Respond to of 12475

Dabur to double sales in three years dabur.com Date: 9/9/99 7:26:11 PM Dabur India Ltd, said on Thursday that it aims to achieve a turnover of Rs 20 bn by financial year 2002-2003, compared to net sales of Rs 9.15 bn in the previous financial year. Dabur has set up a subsidiary in Britain, Axol Laboratories plc, "which will lead the global oncology initiative," Chairman Mr. V.C. Burman told shareholders at its annual general meeting in Delhi. Oncology is the study of tumours. Dabur will set up formulations plant in Britain at a project cost of US $ 9 mn. The statement further said Mr. Burman was confident that Dabur would achieve a higher growth rate and improve profitability in the current financial year.